Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Broto

Showing results (421-430 of 555) with videos related to

Pageof 56
Sort By:
Eclinicalmedicine|September 21, 2023
An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: an observational cohort studyDimitris Bertsimas, Georgios Antonios Margonis, Seehanah Tang, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 28, 2026
Retrospective analysis of TB screening in vulnerable populations in low-burden settingsM A Jiménez-Fuentes, M Luiza de Souza-Galvão, E Lara López, et al.
Cancer Letters|May 23, 2026
NAB2::STAT6 Fusion Proteins Drive Nuclear Condensate Formation and Transcriptional Reprogramming in Solitary Fibrous TumorsYi Li, Jose L Mondaza-Hernandez, Gauthami Pulivendala, et al.
British Journal of Cancer|August 30, 2017
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinibHeikki Joensuu, Jean-Yves Blay, Alessandro Comandone, et al.
Medicina Clinica|July 20, 2019
Effectiveness of a multidisciplinary educational intervention in patients with hip fracture: SWEET HOME studyTeresa Sanclemente-Boli, Sandra Ponce-Ruiz, Consuelo Álvarez-Lorenzo, et al.
Future Oncology (London, England)|February 11, 2025
SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcomaGregory M Cote, Sant P Chawla, George Demetri, et al.
Journal of Surgical Oncology|August 25, 2022
A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysisNicholas M Bernthal, John H Healey, Emanuela Palmerini, et al.
Annals of Surgical Oncology|January 23, 2015
Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS)Jordi Rubió-Casadevall, Javier Martinez-Trufero, Xabier Garcia-Albeniz, et al.
Therapeutic Advances in Medical Oncology|January 30, 2024
Trabectedin and low-dose radiation therapy in patients with advanced leiomyosarcomaJavier Martin-Broto, Alicia Olarte-García, Ricardo Fernandéz-Rodríguez, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 ProtocolJuliana Salazar, María J Arranz, Javier Martin-Broto, et al.
Pageof 56

Showing results (421-430 of 555) with videos related to

Sort By:
Pageof 56
Eclinicalmedicine|September 21, 2023
An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: an observational cohort studyDimitris Bertsimas, Georgios Antonios Margonis, Seehanah Tang, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 28, 2026
Retrospective analysis of TB screening in vulnerable populations in low-burden settingsM A Jiménez-Fuentes, M Luiza de Souza-Galvão, E Lara López, et al.
Cancer Letters|May 23, 2026
NAB2::STAT6 Fusion Proteins Drive Nuclear Condensate Formation and Transcriptional Reprogramming in Solitary Fibrous TumorsYi Li, Jose L Mondaza-Hernandez, Gauthami Pulivendala, et al.
British Journal of Cancer|August 30, 2017
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinibHeikki Joensuu, Jean-Yves Blay, Alessandro Comandone, et al.
Medicina Clinica|July 20, 2019
Effectiveness of a multidisciplinary educational intervention in patients with hip fracture: SWEET HOME studyTeresa Sanclemente-Boli, Sandra Ponce-Ruiz, Consuelo Álvarez-Lorenzo, et al.
Future Oncology (London, England)|February 11, 2025
SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcomaGregory M Cote, Sant P Chawla, George Demetri, et al.
Journal of Surgical Oncology|August 25, 2022
A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysisNicholas M Bernthal, John H Healey, Emanuela Palmerini, et al.
Annals of Surgical Oncology|January 23, 2015
Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS)Jordi Rubió-Casadevall, Javier Martinez-Trufero, Xabier Garcia-Albeniz, et al.
Therapeutic Advances in Medical Oncology|January 30, 2024
Trabectedin and low-dose radiation therapy in patients with advanced leiomyosarcomaJavier Martin-Broto, Alicia Olarte-García, Ricardo Fernandéz-Rodríguez, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 ProtocolJuliana Salazar, María J Arranz, Javier Martin-Broto, et al.
Pageof 56